Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV

• Autors principals: Wang-Da Liu (Autor), Man Wai Pang (Autor), Jann-Tay Wang (Autor), Hsin-Yun Sun (Autor), Yu-Shan Huang (Autor), Kuan-Yin Lin (Autor), Un-In Wu (Autor), Guei-Chi Li (Autor), Wen-Chun Liu (Autor), Yi-Ching Su (Autor), Pu-Chi He (Autor), Chia-Yi Lin (Autor), Chih-Yu Yeh (Autor), Yu-Chen Cheng (Autor), Yi Yao (Autor), Yi-Ting Chen (Autor), Pei-Ying Wu (Autor), Ling-Ya Chen (Autor), Yu-Zhen Luo (Autor), Hsi-Yen Chang (Autor), Wang-Huei Sheng (Autor), Szu-Min Hsieh (Autor), Sui-Yuan Chang (Autor), Chien-Ching Hung (Autor), Shan-Chwen Chang (Autor)
• Format: Llibre
• Publicat: Elsevier, 2022-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: A community COVID-19 outbreak caused by the B.1.1.7 SARS-CoV-2 variant occurred in Taiwan in May 2021. High-risk populations such as people living with HIV (PLWH) were recommended to receive two doses of COVID-19 vaccines. While SARS-CoV-2 vaccines have demonstrated promising results in...